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This review discusses sex differences in the prognosis of acute or chronic inflammatory diseases. The consequences
of severe inflammation vary in relation to sex, depending on illness duration. In the majority of acute diseases,
males present higher mortality rates, whereas continuous chronic inflammation associated with tissue damage is
more deleterious in females. The recruitment of cells, along with its clinical expression, is more significant in
females, as reflected by higher inflammatory markers. Given that estrogens or androgens are known to modulate
inflammation, their different levels in males and females cannot account for the sexual dimorphism observed in
humans and animals from birth to death with regard to inflammation. Numerous studies evaluated receptors,
cytokine production, and clinical outcomes in both animals and humans, revealing that estrogens clearly modulate
the immune response, but the results are contradictory and difficult to link to hormone concentrations. Even in
prepubescent children, the presentation of acute pneumonia or chronic diseases mimics the adult pattern. Several
genes located on the X chromosome have been shown to encode molecules involved in inflammation. Moreover,
10% to 15% of the genes from silenced X chromosome may escape inhibition. Females are also a mosaic of cells
with genes from either paternal or maternal X chromosome. Therefore, polymorphism of X-linked genes would
result in the presence of two cell populations with distinct regulatory arsenals, providing females with greater
diversity to fight against infectious challenges, in comparison with the uniform cell populations in hemizygous
males. The similarities observed between males and Turner syndrome patients using an endotoxin stimulation
model support the difference in gene expression between monosomy and disomy for the X chromosome.
Considering the enhanced inflammation in females, cytokine production may be assumed to be higher in females
than males. Even if all results are not clear-cut, nonetheless, many studies have reported higher cytokine levels in
both male humans and animals than in females. High IL-6 levels in males correlated with poorer prognosis and
shorter longevity. A sound understanding of the basic regulatory mechanisms responsible for these gender
differences may lead to new therapeutic targets.
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Definition of inflammation
In the majority of cases, inflammation is a defense mech-
anism of sudden onset that restores homeostatic balance
in the case of infection, tumor, and traumatic or ischemic
tissue damages. Vascular and exudative processes are pre-
dominant with respect to the clinical signs. They are the* Correspondence: georges.casimir@huderf.be
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reproduction in any medium, provided the orexpression of a protective tissue response to injuries,
which serves to destroy, dilute, or wall off both the injuri-
ous agent and the injured tissues.
Chronic inflammation is less frequent and is mainly
observed in cases of prolonged and persistent inflamma-
tion predominately marked by new connective tissue for-
mation. It tends to persist for several weeks, months, or
years, with a vague and indefinite termination. Chronic
inflammation occurs when the injuring agent (or prod-
ucts resulting from its presence) persists in the lesional
area, and when the host's tissues respond in a manner
(or to a degree) that is insufficient to completely over-
come the continuing effects of the injuring agent.Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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ized by infiltrates of lymphocytes, plasma cells, histio-
cytes, and fibrosis. Local deleterious effects are usually
observed in the affected tissues leading to permanent
organ damages that compromise the disease's prognosis.
At the clinical level, the intensity of inflammation is
measured using inflammatory markers, such as C-reactive
protein (CRP), erythrocyte sedimentation rate (ESR), or
neutrophil count. Higher marker levels are only an indica-
tion of the importance of the inflammatory phenomenon.
Expression of biological markers underlying
inflammatory processes
When analyzing these standard inflammatory biological
markers, significant differences were observed not only in
adults [1] but also between boys and girls younger than 10
years old. Biological parameters increased at the beginning
of the inflammatory process and over time, and CRP, ESR,
and neutrophil counts reached or exceeded threshold
levels, with values being systematically higher in girls than
those in boys. However, at the peak inflammatory re-
sponse, the values observed were rather similar [2]. Neu-
trophil counts were reported to be higher in females of all
ages in several acute inflammatory conditions, such as
post-surgical trauma following gastrectomy [3], exercise-
induced muscle injury [4], coronary artery diseases [5],
children born to hepatitis C-infected women [6], and even
in several basic conditions [7]. Women who subsequently
developed cardiovascular events were shown to display
higher baseline CRP levels than males of corresponding
status [8]. CRP values were also higher in women partici-
pating in the Dallas heart study [9]. Females tended to ex-
hibit higher baseline ESR [10], even during childhood [2],
which was also observed in pathologic conditions, such
as rheumatoid arthritis [11]. The question is, therefore,
whether these sex differences in terms of biological
markers are associated with clinical differences.
Sexual dimorphism in respiratory diseases along the
life course
During the 1970s, hyaline membrane disease-related mor-
tality was higher in boys than that in girls, with ratios ran-
ging from 1.62 to 1.76 in a published meta-analysis [12].
As regards the meconium aspiration syndrome, male neo-
nates were also more prone to develop the disorder than
female neonates [13]. Recent data on 92,332 patients ad-
mitted to pediatric hospitals demonstrated a consistent
excess of males over females (59%) for almost all disease
categories, with 26% of diseases relating to the respiratory
system. Boys were also more susceptible than girls to
acute viral infections, such as bronchiolitis (61% vs. 53%,
P = 0.01) [14]. In a survey involving 7,001 tuberculosis pa-
tients from Bangladesh, the female/male ratio was found
to be 0.33:1 [15]. The tuberculosis case notification ratewas reported to be higher for men than that for women
worldwide [16]. In 2013, tuberculosis epidemiology is still
characterized by significant differences in prevalence rates
between men and women worldwide, with cases among
men exceeding those found in women with a male/female
ratio of 2:1 found in some regions [17]. At any age, boys
outnumber girls in acute inflammatory diseases, and their
prognosis is worse. Better prognosis in females for acute
inflammatory diseases is observed regardless of the age,
while worse outcome concerns females of every age with
chronic inflammation. Compared to age, the chronicity of
the inflammatory process has more adverse effects on girls
than on boys by its collateral perverse consequences.
When inflammation is not reversible, when the power
“ON/OFF” switch of inflammation remains continuously
moved to the ON position, the largest inflammatory
mobilization in girls is responsible for deleterious effects.
The longer of the inflammation of a tissue lasts, the more
damage it does. That could explain the higher mortality in
girls suffering from cystic fibrosis or chronic obstructive
pulmonary disease (COPD) (Table 1).
In a 2-year prospective study covering a well-defined
geographic area of the Spanish Mediterranean coast, the
incidence rates of community-acquired pneumonia were
higher in males (16 vs. 9 cases per 10,000 people per year,
P < 0.0001), in particular among patients aged >75 years,
with 87 cases per 10,000 people found per year in this pa-
tient population [22].
In addition, in animals, there was a male/female bias in
relation to induced occurrence, as male mice consistently
developed a more severe disease in the lung parenchyma
infected by Mycoplasma pulmonis as compared to fe-
males [27].
Male gender was reported to be associated with an
increased risk of pneumonia and poorer pulmonary prog-
nosis in various clinical conditions, including post-injury
and hospitalized community-acquired pneumonia, acute
respiratory distress syndrome, HIV-related Pneumocystis
carinii pneumonia, current respiratory illness in children,
and acute respiratory failure following bone marrow trans-
plantation, along with a higher risk of re-hospitalization
[1,21,23-25,31,36]. In many acute respiratory diseases,
males appear, as they age, to be more susceptible to com-
plications and exhibit a higher mortality [26]. In 1965, an
international literature review by Washburn et al. revealed
a significant male preponderance for respiratory diseases,
especially during infancy [37]. A genetic hypothesis was
proposed, suggesting that a gene locus on the X chromo-
some in humans was involved in the synthesis of immuno-
globulins. The male preponderance and poorer prognosis
status were found not only for respiratory diseases but
also for most acute inflammatory processes. Several stud-
ies from various countries suggested that males, children
as well as adults, were more frequently admitted to
Table 1 Worse prognosis in males in acute diseases and in females during chronic inflammatory diseases
Disease Number of patients Age of patients Significance References
Acute diseases (higher in males)
Hyaline membrane disease 54,064 Premature newborns Ratio 1.76:1 [12]
Meconium aspiration 21,472 Newborns P < 0.02 [13]
Mortality and morbidity of hospitalized children Nearly 500,000 Children P < 0.001 [18]
Severe sepsis in children 1,586,253 Children P < 0.001 [19]
Pediatric hospital admissions 92,332 Children Males 59% [20]
Acute respiratory failure after bone marrow transplantation 318 Children P < 0.04 [21]
Tuberculosis in Bangladesh 266,189 Adults Ratio M/F, 1:0.33 [15]
Tuberculosis in India 90,000 Adults P < 0.05 [16]
Community-acquired pneumonia 2-year prospective study Adults P < 0.0001 [22]
Acute respiratory distress syndrome 333,004 Adults P < 0.01 [23]
Post-injury pneumonia 30,288 More than 65 years P < 0.001 [1]
Hospitalized community-acquired pneumonia 623,718 More than 65 years P < 0.001 [24]
In-hospital community-acquired pneumonia (elderly) 717 More than 65 years P < 0.02 [25]
Australian seniors with chronic respiratory disease 108,312 More than 65 years P < 0.0003 [26]
Mycoplasma respiratory disease (mice) 55 Adult animals P < 0.001 [27]
Chronic respiratory diseases (poorer prognosis in females)
Chronic inflammatory diseases (children) 149 children Children P < 0.01 [28]
Asthma in adolescents (sex ratio in severe asthma 5 F/1 M) 2,693 Adolescents Ratio 1.85:1 [29]
Chronic pulmonary diseases (females smokers) Meta-analysis (55,709) Adults P < 0.008 [30]
HIV-related pneumocystis pneumonia 3,070 Adults P < 0.001 [31]
Cystic fibrosis 21,047 1 to 20 years: females 60% more likely to die, outside same risk P < 0.001 [32]
Asthma 3,013 5 to 62 years P < 0.01 [33]
Chronic obstructive pulmonary diseases (COPD) emergencies 794 Adults P < 0.01 [34]




















Casimir et al. Biology of Sex Differences 2013, 4:16 Page 4 of 9
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require aggressive life support [18,38]. In a recent work on
predictors of sequelae and death following bacterial men-
ingitis in childhood, male gender was reported to be a sig-
nificant prognostic factor, with no satisfactory explanation
found [39]. Even in animals, infectious diseases [40] and
myocardial infarction [41] were associated with poorer
prognosis in males than in females. One possible explan-
ation for this is that inflammatory reactions are likely to
be driven by hormonal status. Nonetheless, this prognostic
difference was even observed in preterm infants, as docu-
mented in several papers [19,42]. Clinical data from pre-
pubertal children suggested that potential gene expression
differences depended on sex chromosomes rather than
hormonal status. Indeed, in these children, hormonal sta-
tus was largely immature, and sexual hormones were far
less abundant, although some studies have shown that in
very young children, the mean estrogen levels—still con-
siderably below adult levels—were eight times higher in
girls than those in boys [43]. Therefore, in prepubescent
children, hormonal differences may still influence the in-
flammatory response.
Higher inflammatory response in girls
Although the inflammatory response was reported to be
higher in females than in males with acute or chronic re-
spiratory diseases [30], the consequences of severe inflam-
mation varied, depending on the inflammatory process.
Females were shown to display a protective advantage in
acute conditions, whereas they were more likely to pre-
sent deleterious tissue damage in relation to continuous
chronic inflammation. Gender differences in terms of clin-
ical outcome indicate that during early childhood, chronic
inflammatory events underlying the physiological disease
mechanism may be more damaging in females than in
males. These observations may explain the results of a
large American study involving more than 21,000 patients
aged 1–20 years that revealed a gender gap in cystic fib-
rosis mortality [32], with girls exhibiting a 60% higher
mortality risk than boys. This difference could not be
accounted for by other risk factors, such as nutritional sta-
tus, pulmonary function, pathogens in sputum, pancreas
insufficiency, or age at diagnosis. In another study relating
to asthma [29], severe cases were more frequent in fe-
males and more persistent in adulthood, with higher mor-
tality rates after 40 years of age. At any age, severe asthma
concerns about 5% of all asthma cases, but females are al-
most five times more likely than males to belong to this
category, even if there is a male preponderance when con-
sidering the whole cohort of asthmatics, with bronchial
hyperreactivity shown to be more common in girls, and
atopy more common in boys [44]. In addition, new data
from a North American population study revealed that
males were 46% less likely to experience asthmaexacerbation than females (odds ratio 0.54, 95% confi-
dence interval 0.31–0.94) [33].
Recently, female gender was associated with poor prog-
nosis of COPD and higher need for post-hospital support
[34]. COPD disease expression was found to be different
in women and men. In addition to its increased prevalence
in females in the case of non-smoker COPD, with patients
being more likely to be female, women were more prone
to have an airway-predominant (chronic bronchitis) phe-
notype, and men more likely to develop an emphysema
phenotype. This observation was considered to be the
consequence of genetic differences in the way males and
females manifest damage. Women experienced more se-
vere dyspnea and anxiety, as well as lower disease-related
quality of life. Furthermore, when discontinuing treatment
with inhaled corticosteroids, women presented a greater
likelihood of respiratory deterioration in comparison with
men [35]. In a recent paper, we reported that chronic in-
flammatory diseases in children were more severe in girls
than in boys [28]. Our data in the prepubescent children
hospitalized for severe exacerbations of chronic asthma
supported the hypothesis that inflammation was enhanced
in girls, requiring higher corticosteroid doses, longer dur-
ation of inhaled therapy, and prolonged hospital stays. In
cystic fibrosis as well, inflammation was more marked in
females, which was also the case for sickle cell anemia,
where we revealed, in line with other authors, that the un-
explained poorer prognosis of females was related to a
lower forced vital capacity [45].
Hormonal influences
While estrogens exhibit diverse effects on inflammation
and immune responses, the molecular basis of these ef-
fects is poorly understood. It is possible that fluctuations
in estrogen levels modulate intracellular signaling for im-
mune responses via estrogen receptors. Based on recent a
data, 17beta-estradiol was shown to increase, at physiolo-
gically high concentrations, the activity of NF-kappa B in
human T cells and induced T cell survival, which may pos-
sibly account for the observed gender dimorphism [46].
However, there are other studies showing that estrogens
can downregulate the NF-kappa B signaling pathway [47].
A further study revealed that female sex hormones (salu-
tary effects) and male sex steroids (suppressing cardiac
and immune functions) were likely to influence the out-
come of trauma patients, although the exact mechanisms
were not clearly understood [48]. There is still an unre-
solved paradox with respect to estrogens regarding their
immunosupportive role in trauma/sepsis and proinflam-
matory effects in certain chronic autoimmune diseases in
humans. The Straub review reinforced the concept that
estrogens exhibit anti-inflammatory and proinflamma-
tory effects, although no uniform concept covering all in-
flammatory conditions could be found because of the
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tems [49].
Recent studies focused on the more robust behavioral
and somatic responses to stress observed in females, and
on the latter's more potent immune and inflammatory re-
actions [50]. Testosterone has been reported to be in-
versely associated to the inflammatory process, especially
to the levels of markers such as C-reactive protein [51].
Numerous studies evaluated receptors, cytokine produc-
tion, and clinical outcomes in both animals and humans,
revealing that estrogens clearly modulate the immune re-
sponse. However, these observations were not sufficient to
readily explain the universal gender difference observed in
acute inflammation, which was found across all age
groups, from premature infants to geriatric patients.
Cytokine expression
In view of the enhanced inflammatory reactions in fe-
males, cytokine production may be assumed to be higher
in females than in males. Some studies did in fact confirm
higher cytokine levels in females, especially in the context
of estrogen stimulation [52]. However, other studies re-
ported that IL-6 levels did not change during the men-
strual cycle [53]. Although estrogens were shown to be
able to slightly modulate cytokine levels, the variations ob-
served were usually not significant or only approached sig-
nificance when considering stimulations at various periods
of the menstrual cycle. In most cases, however, and all
along the life course, cytokine concentrations in response
to inflammatory stimulation were shown to be higher in
males than in females. Estrogen may exhibit pro- and
anti-inflammatory properties depending on the context
and the involved tissue. Several studies have reported a
significantly higher cytokine production in males [54,55],
using ex vivo models in humans [56-59] and animals
[60-62]. On admission to the emergency department, bio-
marker patterns in men were characterized by higher
levels of tumor necrosis factor, interleukin (IL)-6, and IL-
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The table summarizes the main trends observe in the literature. Up arrow denotesrates, as reported by the Genetic and Inflammatory
Markers of Sepsis Investigators Group [54]. In a wild-type
mice model using intraperitoneally injected endotoxin,
males displayed stronger responses than females with re-
spect to myeloid differentiation, myeloid cell release from
bone marrow into peripheral blood, and migration into
the inflammatory peritoneal cavity, demonstrating that sex
differences in inflammatory responses were also observed
in animals [55] (Table 2).
In our first in vitro study, we investigated the influence
of sex on the production of cytokines involved in inflam-
mation by studying healthy prepubescent males and fe-
males, as well as Turner syndrome patients with an XO
genotype (X monosomy) [63]. In this model, despite all
Turner syndrome patients being female, there was a male
pattern of reactivity, with cytokine production response to
endotoxin and pokeweed mitogen (PWM) stimulation of
whole blood cells being higher in males than that in fe-
males, suggesting a genetic-chromosomal influence. Thus,
these findings contrast the numerous clinical observations
revealing in vivo increased inflammatory marker produc-
tion in females. However, in our stimulation model, sex
differences in cytokine production depended on the type
and intensity of the stimulus (0.2 or 1 ng/ml of endotoxin
or PWM), and varied according to the cytokine (IL-1, IL-6
, TNF-α, or PGE-2). We observed that, in both males and
females, TNFα was highly correlated to IL-6, provided that
low doses of lipopolysaccharide or PWM that induced re-
sponses in approximately the same relative range were
used. A strong correlation between IL-6 and IL-1 was
found, but only in the male group. Given the potential
anti-inflammatory effect of IL-6 [64], these relationships
may reflect a regulation of both cytokine levels by con-
comitant IL-6 production. Furthermore, males displayed a
significantly lower variation coefficient (slope) than fe-
males, suggesting that the influence of IL-6 in reducing
IL-1 or TNFα production was more pronounced in males.
Caution must be taken, however, as the interindividual
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model, which has not been confirmed to date. Gregory
et al. investigated sex differences in cell-mediated immun-
ity in both normal and pathological conditions, following
dorsal scald or sham injury in mice [65]. The authors ob-
served differences in both delayed-type hypersensitivity
and splenocyte proliferative responses between males and
females. These responses were significantly suppressed,
with a kinetic profile depending on sex. There was a high
expression of IL-6 at the end of the suppression, while
anti-IL-6 antibodies were shown to restore splenocyte
proliferation, yet only partially in males but completely in
females. This data demonstrates that cell-mediated im-
munity varies according to sex and that the response to
the same inflammatory stimulation differs in males and fe-
males, and this is not only in terms of kinetics (quantita-
tively and qualitatively) but also due to the complex
relationships between inflammatory mediators.
In the lungs, complex cytokine networks have been
observed, whereby inflammatory cells were shown to
regulate fibroblast function, which in turn regulates in-
flammatory cell function. The effect of an individual cyto-
kine varies according to the activation status of the target
cell, presence of other cytokines in the local microenviron-
ment, and ability of the target cell to produce bioactive
autacoids, such as prostaglandins [66]. Another study re-
vealed that the inflammatory response, especially to endo-
toxins, might be predicted by several parameters, such as
the promoter polymorphism of the IL-6 gene, sex with
males displaying enhanced IL-6 levels as compared to fe-
males (P < 0.015), density of the endotoxin receptor
CD14, and finally, the concentration of other cytokines. In
addition, the IL-6 response correlated with the concentra-
tions of the more proximal cytokines, namely tumor ne-
crosis factor-α and interleukin-1β [67].
While age may influence the production of cytokines,
sex differences remain apparent [68]. Considering the
poorer prognosis of males and their higher IL-6 blood
levels, Bonafè et al. investigated 700 subjects aged 60–110
years, including 323 centenarians [69]. The authors
showed that the IL-6 promoter genetic variability at the −
174 C/G locus and its effect on IL-6 serum levels clearly
influenced longevity in homozygous men. The proportion
of subjects homozygous for the G allele at the −174 locus
decreased in centenarian males, but not in centenarian fe-
males. Higher levels of inflammatory markers were pre-
dictive of reduced survival time and shorter lifespan
among men, whereas only IL-6 at high levels was associ-
ated with longevity in post-menopausal women who did
not take estrogens [70].
X-linked genes involved in inflammation
Several proteins involved in immunity are encoded on the
X chromosome and especially protein members of thetoll-like receptor signaling pathway, glucose metabolic en-
zymes, apoptotic cascade enzymes, or proteins with im-
pact on the hormonal balance. Females carry two X
chromosomes, one of which is randomly inactivated dur-
ing early embryogenesis in order to maintain the dosage
balance of proteins for both sexes [71-73]. Females are,
thus, a mosaic of cells with genes from either the paternal
or maternal X chromosome. Therefore, polymorphism of
X-linked genes would result in the presence of two cell
populations with distinct regulatory and functional arse-
nals, providing females with greater diversity to fight
against infectious challenges, in comparison with the uni-
form cell populations in hemizygous males [74-76]. More-
over, up to 15% of the X-linked genes escape inactivation
to some extent, thereby increasing the X-linked cellular
protein content in females compared with that in males
[77,78]. Some of the main protein members of the toll-like
receptor (TLR) and nuclear factor κB (NF-κB) signaling
pathway are linked to the X chromosome: interleukin 1
receptor Y-associated kinase 1, NF-κB essential modulator,
and Bruton's tyrosine kinase.
Chandra et al. used an animal model to investigate
whether female X-chromosome mosaicism for inflamma-
tory gene expression may contribute to the gender di-
morphic response during the host response. Using splenic
T-cell depletion and post-endotoxin IL-10 responses, the
authors showed that the inflammatory response in mosaic
animals did not simply display an average of the deficient
and wild-type responses, but that the mosaic subjects
exhibited a unique characteristic response [79]. In another
study, the authors showed that cellular mosaicism for the
X-linked gp91phox (NOX2) deficiency, the main subunit
of the superoxide anion-generating NADPH oxidase com-
plex, reduced sepsis-induced mortality in deficient mice, as
well as in mosaic animals carrying both deficient and WT
phagocytes. In mosaic animals, the deficient neutrophils
displayed increased organ recruitment and CD11b mem-
brane expression compared with WT neutrophils [80].
In our first in vitro study, the similarities between the
male subjects and Turner syndrome patients in terms of
the cytokine production pattern support a difference in
gene expression between monosomy and disomy for the
X chromosome [63]. More recently, we sought to evaluate
the potential role of the X mosaicism on the expression of
the TLR signaling pathway by measuring the production
of inflammatory cytokines through the NF-κB pathway in
healthy adults using whole blood stimulated by a gram-
negative bacillus endotoxin [81]. In this study, we also ob-
served a higher production of tumor necrosis factor
(TNF)-α, with a trend towards a higher IL-6 production,
in men. TNF-α production significantly correlated with
monocyte counts, with men exhibiting a higher monocyte
count than women. One of our hypotheses is that, in
males, an early release of high TNF-α and IL-6 levels by
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tributing to the higher mortality in septic shock observed
in males versus females.
In autoimmune diseases [82], immune response genes
were shown to be significantly over-represented among
genes upregulated in women and among the immune
response genes, with the inflammatory/cytotoxic effector
genes interferon-γ, lymphotoxin β, granzyme A, interleu-
kin-12 receptor β 2, and granulysin being among those
overexpressed to the greatest extent. In contrast, inter-
leukin-17A was the only effector gene found to be more
strongly expressed in men.
Another particularity of the X chromosome, which may
be involved in the immune sex dimorphism, is the spread-
ing of the inactivation signal along the pseudoautosomal
(PAR1) region of the X chromosome. The accidental
methylation of this region may result in partial silencing
of genes lying close to the boundary between the PAR1 re-
gion and X-linked material. In our study, the percentage
of the monocytes expressing CD99 was higher in men
than that in women, thus confirming the higher CD99 ex-
pression reported in males using reverse transcription
polymerase chain reaction [71]. CD99 is known to play a
role in leukocyte diapedesis, and its gene lies closest to the
boundary between the PAR1 and X-linked regions. Conse-
quently, a difference in the percentage of monocytes ex-
pressing CD99 could affect monocyte recruitment to the
inflamed tissues. Increased CD99 expression due to an X;
Y translocation was linked to the early development of a
chronic inflammatory disease known to be associated with
an imbalanced sex ratio [83]. Some genes implicated in
the immune response and located on the X chromosome,
such as X-linked genes encoding the proteins of the TLR
signaling pathway or genes of the pseudoautosomal PAR1
region such as the CD99 gene, could be responsible for
some of the sex-specific responses to inflammation.
Therefore, as mosaicism for X-linked polymorphisms may
be of clinical relevance, this should be considered in gen-
etic association or sex-related clinical studies.
Conclusions
The investigation of the inherent biological advantages of
healthy normal females may lead to new therapeutic strat-
egies aimed to improve anti-infectious responses in males.
Anti-inflammatory drugs exert differing effects on both
animals and humans depending on gender [84-86]. Sex
may influence the potency of test compounds, such as ste-
roids, or the doses to be used; sex may also determine the
phenotype answer to specific drugs. In a 2003 study in-
volving 60,694 Californian asthmatic subjects, females
aged 14 to 22 years were found to be more likely outpa-
tients or visit emergency departments and use more oral
corticosteroids compared to males [87]. Although females
with chronic inflammation used more corticosteroids thanmales, their prognosis was poorer. Even in animals,
chronic inflammation was more significant in females
[88]. Accordingly, a better understanding of the inflamma-
tory mechanisms involved in chronic inflammatory pro-
cesses may be instrumental in decreasing deleterious
tissue damage and, thus, be of great benefit for women.
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